Drug Insights

Optimize Your Synapse Experience: A Step-by-Step Guide to Searching Dopamine

19 February 2024
2 min read

Dopamine hydrochloride, first approved in the USA on February 25, 1974, is a medication developed and marketed by Hospira. It is indicated for the treatment of heart failure and shock. Dopamine hydrochloride works as a dopamine agonist, which means that it binds to and activates dopamine receptors in the body. This results in increased cardiac output and improved blood flow to vital organs. The chemical name for dopamine hydrochloride is 3,4-dihydroxyphenethylamine hydrochloride. As the hydrochloride salt form of dopamine, it is more stable and soluble in water, making it suitable for intravenous administration in clinical settings. Click on the image below to begin the exploration journey of Dopamine through the Synapse database!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

US FDA & Australian Health Authorities Approve ETX101, Encoded Therapeutics' Potential Genetic Treatment for Dravet Syndrome
Latest Hotspot
3 min read
US FDA & Australian Health Authorities Approve ETX101, Encoded Therapeutics' Potential Genetic Treatment for Dravet Syndrome
18 February 2024
Encoded Therapeutics Reveals Approval from US FDA for IND Application and Consent from Australian Health Authorities for ETX101, a Genetic Treatment Prospect for Dravet Syndrome.
Read →
An analysis of LY-3537982's R&D progress and its clinical results presented at the 2024 ASCO_GI Annual Meeting
An analysis of LY-3537982's R&D progress and its clinical results presented at the 2024 ASCO_GI Annual Meeting
18 February 2024
LY3537982: A Potent Oral Inhibitor for KRAS G12C Mutation in GI Tumors - Results from 2024 ASCO-GI LOXO-RAS-20001 Phase 1 Study.
Read →
Scholar Rock Unveils Initial Lab Results Indicating Advantages of SRK-439 in Supporting Weight Reduction
Latest Hotspot
3 min read
Scholar Rock Unveils Initial Lab Results Indicating Advantages of SRK-439 in Supporting Weight Reduction
18 February 2024
Scholar Rock's Study Reveals SRK-439's Potential Influence on Muscle Mass and Metabolic Health in Weight Loss Efforts.
Read →
The Synapse User's Toolkit: Tips for Searching Naltrexone
Drug Insights
2 min read
The Synapse User's Toolkit: Tips for Searching Naltrexone
18 February 2024
Naltrexone, an opioid antagonist, has been utilized for treating addiction to both drugs and alcohol.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.